Oh Daniel M, Johnson Jacklyn, Shah Bankim, Bhat Sushanth, Nuoman Rolla, Ming Xue
Rutgers New Jersey Medical School, Department of Neurology, 150 Bergen St., Newark, NJ 07103, United States of America.
Riverside Medical Group, Bayonne Sleep Medicine, 432 Broadway, Bayonne, NJ 07002, United States of America.
Epilepsy Behav Rep. 2019 Jun 22;12:100325. doi: 10.1016/j.ebr.2019.100325. eCollection 2019.
Vagus nerve stimulation (VNS) is a treatment option for patients with drug-resistant seizures, but it is also associated with sleep-disordered breathing (SDB). We present four patients with VNS who underwent polysomnography (PSG) concurrently with VNS stimulation monitoring and adjustment, and positive airway pressure (PAP) treatment. We demonstrate the importance of sleep apnea screening prior to VNS placement and the dilemma of optimizing VNS settings.
VNS is a common adjunct therapy for refractory epilepsy. Despite its low side effect profile, complications of VNS include delayed arrhythmias, laryngopharyngeal dysfunction, obstructive sleep apnea, and tonsillar pain mimicking glossopharyngeal neuralgia. Risk of developing or exacerbating existing obstructive sleep apnea (OSA) limits the VNS settings, as there appears to be a dose dependent effect. OSA can further cause sleep fragmentation and cause hypoxia, potentially worsening seizures.
Four patients with drug-resistant epilepsy with VNS underwent PSG with concurrent VNS leads to monitor correlation of SDB and VNS. AHI was calculated to quantify SDB, and it was scored as non-VNS related when the VNS was off, and VNS-induced when the onset of SDB corresponded to VNS activation. Subsequent PAP and VNS adjustment was performed to treat the SDB episodes.
Three out of four patients had non-VNS associated SDB, which improved with PAP treatment. All four patients had VNS-induced SDB episodes but none improved with PAP. The VNS-induced SDB events decreased in a dose dependent manner, when VNS was adjusted down and disappeared when turned off completely.
Our case series provides further evidence of VNS-induced SDB secondary to VNS. PAP treatment alone is ineffective for VNS-induced SDB. Screening for OSA before VNS implant is crucial; further research is needed to establish optimal VNS parameters for prevention andminimization of VNS-induced SDB along with other possible treatments.
迷走神经刺激(VNS)是耐药性癫痫患者的一种治疗选择,但它也与睡眠呼吸障碍(SDB)有关。我们报告了4例接受VNS治疗的患者,他们在进行VNS刺激监测和调整的同时接受了多导睡眠图(PSG)检查以及气道正压(PAP)治疗。我们证明了在植入VNS之前进行睡眠呼吸暂停筛查的重要性以及优化VNS设置的困境。
VNS是难治性癫痫的一种常见辅助治疗方法。尽管其副作用较少,但VNS的并发症包括延迟性心律失常、喉咽功能障碍、阻塞性睡眠呼吸暂停和类似舌咽神经痛的扁桃体疼痛。发生或加重现有阻塞性睡眠呼吸暂停(OSA)的风险限制了VNS的设置,因为似乎存在剂量依赖性效应。OSA可进一步导致睡眠片段化并引起缺氧,可能会使癫痫发作恶化。
4例接受VNS治疗的耐药性癫痫患者在进行PSG检查时同时使用VNS导联,以监测SDB与VNS的相关性。计算呼吸暂停低通气指数(AHI)以量化SDB,并在VNS关闭时将其评定为与VNS无关,而当SDB发作与VNS激活相对应时评定为VNS诱发。随后进行PAP和VNS调整以治疗SDB发作。
4例患者中有3例存在与VNS无关的SDB,经PAP治疗后有所改善。所有4例患者均有VNS诱发的SDB发作,但经PAP治疗均无改善。当VNS调低时,VNS诱发的SDB事件呈剂量依赖性减少,完全关闭时则消失。
我们的病例系列进一步证明了VNS可继发引起SDB。单独的PAP治疗对VNS诱发的SDB无效。在植入VNS之前筛查OSA至关重要;需要进一步研究以确定预防和最小化VNS诱发的SDB以及其他可能治疗方法的最佳VNS参数。